UPDATE : Monday, September 7, 2020
상단여백
'Ethnic differences affect optimal care path for inflammatory bowel disease' by Shim Hyun-tai 2020-07-21 17:40
Helixmith to start trials of VM202 for treating rare disorder by Lee Han-soo 2020-07-21 17:10
Genexine, Y Biologics to co-develop Covid-19 treatment by Lee Han-soo 2020-07-21 15:52
GC LabCell’s tech wins patent for delivering gene therapy to brain by Shim Hyun-tai 2020-07-21 15:52
'Severe atopic dermatitis drug too expensive for adolescents' by Kim Eun-young 2020-07-21 14:20
라인
Cluster infections at adult daycare facility push back new virus cases by Lee Han-soo 2020-07-21 14:18
[Column] Give choice to opt-out Oriental medicine from health insurance coverage   by Park Jae-young Executive editor 2020-07-21 11:46
KUAH researchers develop tech on stem cells for leukemia patients by Shim Hyun-tai 2020-07-20 21:28
GC makes plasma Covid-19 therapy for clinical trials by Shim Hyun-tai 2020-07-20 17:30
Will interferon blocker work on severe Covid-19 patients? by Kim Eun-young 2020-07-20 14:53
라인
New virus cases fell to 3-week low by Shim Hyun-tai 2020-07-20 13:40
KHIDI warns of impersonation fraud on website by Kwak Sung-sun 2020-07-20 11:43
Eutilex’s cancer therapy won Canadian patent by Shim Hyun-tai 2020-07-17 17:52
'Diabetes independent risk factor for severe, critical Covid-19 outcomes’ by Lee Han-soo 2020-07-17 17:44
Chunlab launches new platform to trace mutated Covid-19 virus by Shim Hyun-tai 2020-07-17 17:44
라인
Doctors, pharmacists push to thwart insurance benefits for herbal medicines by Choi Gwang-seok 2020-07-17 15:54
Junior nurses still bullied despite anti-harassment law by Kwak Sung-sun 2020-07-17 15:40
Celltrion’s Covid-19 diagnostic kit gets CE certification by Lee Han-soo 2020-07-17 15:39
New virus cases hover around 60 by Lee Han-soo 2020-07-17 12:45
EIU report assesses rare disease situations in Asia-Pacific by Shim Hyun-tai 2020-07-16 17:58
여백
여백
여백
Back to Top